Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novuspharma antitumor agents particularly effective against solid tumors

Sep. 12, 2001

Targeted apoptosis research program at Antisoma expanded by newly acquired rights from NIH

Sep. 12, 2001

FDA panel emits positive recommendation for Zevalin

Sep. 12, 2001

Clinical trial of Cur-61414 commences for treatment of sporadic BCC

Sep. 12, 2001

Joint Onco TCS clinical development program expanded

Sep. 12, 2001

WHI-P131: a dual-acting antileukemic, anti-GVHD compound targeting JAK3

Sep. 10, 2001

HGS initiates new clinical trial with repifermin for treatment of mucositis

Sep. 10, 2001

Simplified salicylihalimide analogues which retain antitumor activity

Sep. 10, 2001

Modified second-generation taxoids: design and SAR discussed at ACS

Sep. 10, 2001

SCRAS patents new series of somatostatin receptor ligands

Sep. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...